Jasco/Roswell Park Research on PIM Inhibitors Presented at ASH Annual Meeting
Monday, December 9, 2013 - 09:30
in Health & Medicine
Jasco Pharmaceuticals and Roswell Park are sharing research results on use of a novel PIM2 inhibitor to overcome multi-drug resistance at the American Society of Hematology (ASH) Annual Meeting.